Insula Neuromodulation for Chronic Neuropathic Pain

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 29, 2027

Conditions
Neuropathic PainChronic Pain
Interventions
DEVICE

neuromodulation

"During the inpatient phase of the study, insular mapping will be performed with electrical stimulation to implanted SEEG electrodes in order to optimize the region for trial stimulation.~Subjects who respond favorably to trial stimulation in the hospital, will progress to the outpatient clinical trial phase where a DBS system will be implanted. All subjects will be blindly randomized to 3 months of stimulation and 3 months of sham stimulation."

Trial Locations (1)

22903

RECRUITING

University of Virginia, Charlottesville

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

University of Virginia

OTHER